Corporate information
Registration country
Company type
Venture firm accelerating life-changing solutions to cure, prevent, and treat type 1 diabetes (T1D) through catalytic commercial investments.Overview
As a venture philanthropy fund, we approach investment opportunities slightly differently than either a venture capital fund or a non-profit organization. We are looking for: Concentrated mission impact: All our companies must have or be developing a T1D program with significant potential for clinical impact. We are primarily focused on cure therapies. Potential for financial return: Each company must have an investable business model so we can attract multiples of private capital and biopharma industry capital. Our investments and our investors are not limited to just the U.S., but are from across the global community. And we work closely with JDRF affiliates in the UK, Canada, Australia, Denmark, Israel and the Netherlands. We follow an investment model typical to a $100m venture fund or small corporate strategic fund. All private capital raised is recorded as a charitable donation and receives associated tax benefits at the time of contribution.Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 1 of 1| Company | Profile | Country | Funding | ||
|---|---|---|---|---|---|
|
Biolinq Inc | N/A |